Dysregulation of MYC in leukemia and lymphoma, which mostly leads to overexpression, is mainly due to gene amplification, chromosomal translocations, aberrant transcription, and increased stability of mRNA and protein [28]. This evidence concerns the gene MYC and lymphoma.